REMIX
Price
$14.41
Change
-$0.08 (-0.55%)
Updated
Oct 7 closing price
Net Assets
745.39M
WGLSX
Price
$12.34
Change
-$0.06 (-0.48%)
Updated
Oct 7 closing price
Net Assets
41.99M
Interact to see
Advertisement

REMIX vs WGLSX

Header iconREMIX vs WGLSX Comparison
Open Charts REMIX vs WGLSXBanner chart's image
Standpoint Multi-Asset Investor
Price$14.41
Change-$0.08 (-0.55%)
VolumeN/A
Net Assets745.39M
Wasatch Long/Short Alpha Institutional
Price$12.34
Change-$0.06 (-0.48%)
VolumeN/A
Net Assets41.99M
REMIX vs WGLSX Comparison Chart in %
View a ticker or compare two or three
VS
REMIX vs. WGLSX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMIX is a Hold and WGLSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REMIX has more cash in the bank: 745M vs. WGLSX (42M). REMIX pays higher dividends than WGLSX: REMIX (5.52) vs WGLSX (0.00). REMIX was incepted earlier than WGLSX: REMIX (6 years) vs WGLSX (4 years). WGLSX (2.09) is less costly to investors than REMIX (1.64). REMIX has a lower initial minimum investment than WGLSX: REMIX (2500) vs WGLSX (100000). REMIX annual gain was more profitable for investors over the last year : 3.33 vs. WGLSX (-19.06).
REMIXWGLSXREMIX / WGLSX
Total Expense Ratio1.512.0773%
Annual Report Gross Expense Ratio1.642.0978%
Fund Existence6 years4 years-
Gain YTD1.613-12.367-13%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets745M42M1,774%
Annual Yield % from dividends5.520.00-
Returns for 1 year3.33-19.06-17%
Returns for 3 years14.7834.9342%
Returns for 5 years54.32N/A-
Returns for 10 yearsN/A39.90-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SER5.400.21
+4.05%
Serina Therapeutics
EURKU10.89N/A
N/A
Eureka Acquisition Corp.
HLLY2.95-0.03
-1.01%
Holley
NVCR14.16-0.34
-2.34%
NovoCure Limited
BIO296.52-12.65
-4.09%
Bio-Rad Laboratories IncClass A